[Evaluation of the therapeutic action of nigeksin in progressive myopia in children].
Levchenko
O G
OG
D000293:Adolescent; D002648:Child; D004338:Drug Combinations; D004341:Drug Evaluation; D005123:Eye / Q000187:drug effects / Q000503:physiopathology; D006439:Hemodynamics / Q000187:drug effects; D006801:Humans; D009216:Myopia / Q000188:drug therapy* / Q000503:physiopathology; D009525:Niacin / Q000627:therapeutic use*; D013607:Tablets; D013805:Theobromine / Q000031:analogs & derivatives* / Q000627:therapeutic use; D013997:Time Factors; D014665:Vasodilator Agents / Q000627:therapeutic use*
D004338:Drug Combinations; D013607:Tablets; D014665:Vasodilator Agents; D009525:Niacin; C007942:pentifylline; D013805:Theobromine
Otsenka lechebnogo deĭstviia nigeksina pri progressiruiushcheĭ blizorukosti u deteĭ.